Farr Miller & Washington’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,439
Closed -$223K 192
2021
Q2
$223K Hold
2,439
0.01% 178
2021
Q1
$208K Hold
2,439
0.01% 182
2020
Q4
$230K Hold
2,439
0.02% 161
2020
Q3
$212K Hold
2,439
0.02% 160
2020
Q2
$213K Hold
2,439
0.02% 150
2020
Q1
$201K Hold
2,439
0.02% 128
2019
Q4
$231K Hold
2,439
0.02% 135
2019
Q3
$212K Hold
2,439
0.02% 134
2019
Q2
$223K Sell
2,439
-283
-10% -$24K 0.02% 130
2019
Q1
$234K Hold
2,722
0.02% 132
2018
Q4
$209K Hold
2,722
0.02% 127
2018
Q3
$210K Buy
+2,722
New +$201K 0.02% 144
2018
Q1
Sell
-2,722
Closed -$205K 160
2017
Q4
$205K Hold
2,722
0.02% 156
2017
Q3
$209K Sell
2,722
-580
-18% -$43.8K 0.02% 155
2017
Q2
$247K Buy
3,302
+11
+0.3% +$780 0.02% 142
2017
Q1
$219K Hold
3,291
0.02% 139
2016
Q4
$215K Hold
3,291
0.02% 131
2016
Q3
$232K Sell
3,291
-419
-11% -$30.5K 0.03% 124
2016
Q2
$274K Sell
3,710
-36
-1% -$2.49K 0.03% 108
2016
Q1
$243K Buy
+3,746
New +$255K 0.03% 120
2015
Q3
Sell
-2,385
Closed -$210K 142
2015
Q2
$210K Hold
2,385
0.02% 138
2015
Q1
$211K Buy
+2,385
New +$212K 0.02% 133
2014
Q4
Sell
-2,385
Closed -$201K 134
2014
Q3
$201K Sell
2,385
-139
-6% -$11.2K 0.03% 126
2014
Q2
$205K Buy
+2,524
New +$199K 0.03% 140

Other funds holding NVS

Farr Miller & Washington's NVS Position: Q3 2021 in Review

Farr Miller & Washington sold out of Novartis (NVS) in Q3 2021, closing a stake of 2,439 shares — an estimated $223K sold.

Farr Miller & Washington first reported a position in NVS in Q2 2014 and held it in 24 quarters. The position peaked at $274K in Q2 2016. 1,080 funds tracked by Wall St. Rank hold NVS as of Q3 2021.

  • Farr Miller & Washington reported no remaining Novartis position as of Q3 2021 after selling out during the quarter.
  • Farr Miller & Washington sold 2,439 Novartis shares in Q3 2021, an estimated $223K.
  • Farr Miller & Washington first reported a position in Novartis in Q2 2014 and held it in 24 quarters.
  • Farr Miller & Washington's Novartis position peaked at $274K in Q2 2016.
  • 1,080 funds tracked by Wall St. Rank held Novartis as of Q3 2021.

Based on Farr Miller & Washington's 13F filing for Q3 2021, filed 15 Nov 2021.